Cellular and molecular effects of PNCK, a non-canonical kinase target in renal cell carcinoma

Derek J Essegian1, Valery Chavez2, Floritza Bustamante2

  • 1Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

Iscience
|December 5, 2022
PubMed

Insights

Pregnancy-upregulated non-ubiquitous calcium-calmodulin-dependent kinase (PNCK) is highly overexpressed in advanced renal cell carcinoma (RCC), driving tumor growth and poor survival. Targeting PNCK presents a promising new therapeutic strategy for this fatal cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Advanced renal cell carcinoma (RCC) remains a significant cause of cancer mortality, with current treatments offering limited long-term efficacy for many patients.
  • Despite advances in immunotherapy and tyrosine kinase inhibitors, a substantial proportion of patients with advanced RCC eventually succumb to the disease, highlighting the need for novel therapeutic targets.

Purpose of the Study:

  • To identify novel therapeutic targets in renal cell carcinoma (RCC) by conducting a comprehensive pan-cancer, pan-kinome analysis.
  • To investigate the biological role and clinical significance of pregnancy-upregulated non-ubiquitous calcium-calmodulin-dependent kinase (PNCK) in RCC progression and patient outcomes.

Main Methods:

  • Utilized the Cancer Genome Atlas (TCGA) for a pan-cancer, pan-kinome analysis to identify differentially overexpressed kinases in RCC.
  • Performed functional studies involving PNCK knockdown in RCC cells to assess its impact on cell proliferation, apoptosis, cell cycle, and key signaling pathways.
  • Conducted pathway analyses to elucidate the molecular mechanisms regulated by PNCK in RCC.

Main Results:

  • Pregnancy-upregulated non-ubiquitous calcium-calmodulin-dependent kinase (PNCK) was identified as the most differentially overexpressed kinase in RCC across the TCGA dataset.
  • PNCK overexpression positively correlated with advanced tumor stage, higher tumor grade, and poorer patient survival.
  • PNCK knockdown led to decreased cell proliferation, cell cycle progression, and increased apoptosis, alongside significant downregulation of hypoxia and angiogenesis pathways.

Conclusions:

  • This study establishes the critical role of PNCK in the pathogenesis of renal cell carcinoma (RCC), demonstrating its involvement in tumor progression and survival.
  • The findings validate PNCK as a novel, druggable target for therapeutic intervention in advanced RCC.
  • Further research into PNCK-targeted therapies holds significant promise for improving outcomes in patients with this aggressive cancer.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.3K